PGNX

Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock

[GlobeNewswire] – TARRYTOWN, N.Y. — Progenics Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 7,608,696 primary shares of its common stock at a public offering price of $4.60 per … moreView todays social media effects on PGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Progenics is hiring next, click here to view […]

Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock

[GlobeNewswire] – TARRYTOWN, N.Y. — Progenics Pharmaceuticals, Inc. announced today that it is offering to sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. Jefferies … moreView todays social media effects on PGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Progenics is hiring next, click here to view […]

2 Deaths, 25% Plunge – And Still A Big Upside

moreView todays social media effects on PGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Progenics is hiring next, click here to view […]

Progenics Pharmaceuticals to Host Conference Call to Review Fourth Quarter Financial Results on March 15

[at noodls] – TARRYTOWN, N.Y., March 8, 2013 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) announced today that it will host a conference call and webcast to discuss its financial results for the … moreView todays social media effects on PGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Progenics is hiring next, click here to view […]